Serum levels of ciprofloxacin after single oral doses in patients with septicemia
- 1 December 1989
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 8 (12) , 1019-1023
- https://doi.org/10.1007/bf01975162
Abstract
Ciprofloxacin serum levels were measured after administration of the drug to 36 patients with septicemia (at least one positive blood culture) who were able to take oral medication. Patients were randomly allocated to receive ciprofloxacin 500 mg p.o. (n=21) or 200 mg i.v. over 30 min (n=15). A first dose was administered 18–30 h after the last positive blood culture (day 1), and a second dose four days later (day 5) in some patients. In addition to ciprofloxacin, standard antibiotics were administered. Organisms isolated wereEscherichia coli (15), other gram-negative bacteria (6),Streptococcus pneumoniae (7),Staphylococcus aureus (2), and other gram-positive bacteria (6). None of the patients vomited. Ciprofloxacin serum concentrations 1 h after oral administration were in the range 0.09–2.32 mg/l, and 2 h after administration in the range 0.5–7.27 mg/l. The average terminal half-life was 8.6 h. In individual patients serum concentrations and area-under-the-curve values were compared. Poor correlation was found between values measured on day 1 and day 5 after oral administration, whereas the correlation was excellent after i.v. administration. Serum levels 2 h after oral administration were 30–900 times the MICs for the gram-negative organisms, but were in the range of the MICs for the gram-positive organisms in some cases. In conclusion, ciprofloxacin serum levels are difficult to predict in septicemia patients after oral administration, but probably suffice to treat infections caused by gram-negative organisms.Keywords
This publication has 12 references indexed in Scilit:
- Comparative evaluation of the BCB Roche and Oxoid Signal blood culture systemsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Clinical Pharmacokinetics of the Newer Antibacterial 4-QuinolonesClinical Pharmacokinetics, 1988
- Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis.1987
- Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients.1987
- Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patientsJournal of Antimicrobial Chemotherapy, 1986
- Pharmacokinetics of Ciprofloxacin in Elderly SubjectsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1986
- Pharmacokinetics of Ciprofloxacin after Intravenous and Increasing Oral DosesPublished by Springer Nature ,1986
- In-vitro activity of newer quinolones against aerobic bacteriaJournal of Antimicrobial Chemotherapy, 1986
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985
- Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteersEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984